ArticleOphthalmology and therapy2022

Outcomes of Escalating Immunosuppressive Treatments for Recalcitrant Noninfectious Posterior Scleritis.

Yuan Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.